B2M and amyloidosis: The first one is dialysis‐related amyloidosis (DRA), in which the wild type (WT) form of β2‐m generates amyloid deposits in patients that undergo long‐term dialysis, when this protein is not efficiently cleared from serum and its concentration increases from an average of 0.16–3.2 μM.3